Loading …

Germantown’s Precigen Announces Pricing of $112.5 Million Public Offering of Common Stock

Published on : January 22, 2021January 22, 2021 Published by : BioBuzz Media

$7.50 per share

First Car-T for an Autoimmune Disease Enters Clinic

Published on : November 5, 2019September 26, 2020 Published by : Chris Frew

First Car-T for an Autoimmune Disease Enters Clinic Maryland-Based Cartesian Therapeutics Initiates CAR-T Clinical Trial in Myasthenia Gravis Gaithersburg, MD, November 5, 2019 – see full press release Founded in [….]

Germantown’s Precigen Announces Pricing of $112.5 Million Public Offering of Common Stock

First Car-T for an Autoimmune Disease Enters Clinic

Gene Editing with CRISPR Training Workshop

In Celebration of Women’s History Month: Closing the Gap in Access to Capital

Single Cell RNA-Seq Training Workshop